Joy Melnikow, MD, MPH - Family Medicine

Board Certifications

American Board of Family Practice—1987, 1993, 1999, 2005

Healthwise Knowledgebase Topics Reviewed

Dr. Melnikow serves as primary medical reviewer for women's health-related topics, such as Abnormal Pap Test, Breast-Feeding, Menopause, topics on sexually transmitted diseases, and a variety of medical test topics related to women's health.

Education

MPH in Epidemiology: University of California, Berkeley, School of Public Health, 1983

M.D.: University of California, San Francisco, School of Medicine, San Francisco, 1984

Residency: Family Medicine, University of Massachusetts, 1984–1987

Academic Appointments

Professor, Dept. of Family and Community Medicine, University of California, Davis, Sacramento, 2002–present

Associate Professor, Dept. of Family and Community Medicine, University of California, Davis, Sacramento, 1998–2002

Assistant Professor, Dept. of Family Medicine, Case Western Reserve University School of Medicine, Cleveland, 1992–1998

Faculty Physician/Research Director, MetroHealth Medical Center, Dept. of Family Practice, Cleveland, 1988–1992

Hospital Affiliations

Fort Defiance Indian Hospital, Fort Defiance, AZ, 1987–1988

MetroHealth Medical Center, Cleveland, 1988–1992

University of California, Davis, Medical Center, 1992–present

Professional Affiliations

American Academy of Family Physicians

American Public Health Association

California Academy of Family Physicians

North American Primary Care Research Group

Society for Medical Decision-Making

Society of Teachers of Family Medicine

Selected Publications

1. Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J (2006). Chemoprevention: Drug pricing and mortality: The case of tamoxifen. Cancer, 107(5): 950–958.
2. Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF (2006). Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstetrics and Gynecology, 107(2 Pt 1): 321–328.
3. Sawaya GF, McConnell J, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. (2003). Risk of cervical dysplasia and cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine, 349(16): 1501–1509.
4. Melnikow J, et al. (2003). Management of low-grade abnormal Pap smear: What are women's preferences? Journal of Family Practice, 51(10): 849–855.
5. Nuovo J, Melnikow J, Chang D (2002). Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 282(21): 2813–2814.

Financial Disclosure

This reviewer reported no financial conflicts.